Re: Results of a randomized trial of treatment modalities in patients with low or early‑intermediate risk prostate cancer (PREFERE trial)

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY(2021)

引用 8|浏览1
暂无评分
摘要
The authors of this “Letter to the Editors” express their major concern about selective and biased reporting in this paper.
更多
查看译文
关键词
risk prostate cancer,prostate cancer,prefere trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要